Oklahoma announces settlement in suit against opioid maker
Some families are upset the case won't go to trial
OKLAHOMA CITY, Okla. — Families torn apart by opioid addiction are reacting with anger and hope to news of a multimillion-dollar settlement reached by the maker of OxyContin and the state of Oklahoma.
Oklahoma officials announced Tuesday the details of a $270 million deal with Purdue Pharma . Numerous lawsuits accuse the company of minimizing the addiction risk and pushing doctors to up dosages even as overdoses climbed. The company has made billions of dollars manufacturing the painkiller.
Oklahoma’s attorney general says he went to great lengths to ensure that the drugmaker doesn’t declare bankruptcy to avoid a paying a hefty settlement.
Announcing the settlement Tuesday, Attorney General Mike Hunter said the state has ” a commitment that they’re not filing for bankruptcy in the near term. ”
Purdue Pharma officials acknowledged this month that the company is considering filing for bankruptcy because of the crush of lawsuits targeting it and other opioid producers.
The settlement comes two months before the Oklahoma case was set for trial.
The agreement angers some families who say a trial is the best way to hold the drug company responsible. Others see hope that much of the money will go toward a National Center for Addiction Studies and Treatment at Oklahoma State University in Tulsa.
COPYRIGHT 2020 BY KOAM. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.